Genedrive completes £500,000 placing as part of wider AIM fundraising

The latest update is out from Genedrive ( (GB:GDR) ).

Genedrive has completed a placing of 50,000,000 new shares at 1.0 pence each, raising gross proceeds of £500,000 as part of a wider fundraising package that also includes a proposed £3.5 million direct subscription and an open offer of up to approximately £1.5 million to existing shareholders. The fundraising, largely conditional on shareholder approval at an early March general meeting and on admission of the new shares to trading on AIM, will significantly expand the company’s share capital and offers existing investors a chance to participate, while the detailed timing and terms of the open offer will be set out in a forthcoming circular.

The most recent analyst rating on (GB:GDR) stock is a Sell with a £1.00 price target. To see the full list of analyst forecasts on Genedrive stock, see the GB:GDR Stock Forecast page.

Spark’s Take on GB:GDR Stock

According to Spark, TipRanks’ AI Analyst, GB:GDR is a Neutral.

The score is held back primarily by weak financial performance—large ongoing losses, sustained cash burn, and a shrinking equity base despite minimal debt. Technicals are moderately supportive with price above key moving averages and positive MACD, but elevated RSI signals near-term overheating risk. Valuation remains challenging due to negative earnings (negative P/E).

To see Spark’s full report on GB:GDR stock, click here.

More about Genedrive

Genedrive plc is a UK-based pharmacogenetic testing company focused on low-cost, rapid, point-of-care genetic diagnostics that help clinicians tailor drug choice and dosage, particularly in time-critical emergency care. Its flagship products, the Genedrive MT-RNR1 ID Kit and Genedrive CYP2C19 ID Kit, are deployed on its proprietary thermocycler platform and were developed with NHS partners for use at the point of care.

Average Trading Volume: 8,782,537

Technical Sentiment Signal: Sell

Current Market Cap: £11.33M

See more data about GDR stock on TipRanks’ Stock Analysis page.